Start with the actual vial
FDA-approved medicines, lawfully compounded preparations, and research chemicals are distinct categories. FDA explains that compounded medicines do not receive premarket approval and that contamination or incorrect strength can cause serious harm. A supplier’s certificate of analysis does not, by itself, establish legal eligibility for patient treatment. Ask counsel to assess the supply arrangement alongside a qualified clinician’s safety review. [1]
Where a civil claim can begin
An injured patient may challenge product selection, screening, consent, administration, or follow-up. The viable claim and standard of care depend on state law and the evidence. Advertising can create another dispute when a clinic promises results it cannot substantiate. “FDA registered” should not be presented as product approval. Clinical consent and a disclaimer cannot be treated as substitutes for lawful sourcing and competent care. [2]
When criminal counsel may be needed
Section 333 provides criminal penalties for prohibited drug-law conduct, including enhanced penalties for certain repeat offenses or intent to defraud or mislead. [3] If investigators request an interview, records, or information about sourcing, arrange prompt legal review. Counsel can identify the scope of the request, preserve records, and coordinate a response without guessing about the clinic’s obligations.
What a focused legal review should address
Map who orders, receives, prescribes, administers, and bills for each product. Review patient-state licensing, ownership and supervision arrangements, vendor contracts, website claims, consent documents, complaint procedures, and insurance notice requirements. Identify any activity that must stop or change. The goal is a defensible operating plan based on the practice’s actual facts.